Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $427.90 | 6 | 76.0% |
| Education | $135.10 | 5 | 24.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $191.56 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $131.02 | 2 | $0 (2017) |
| Insulet Corporation | $88.19 | 1 | $0 (2022) |
| Radius Health, Inc. | $85.09 | 2 | $0 (2024) |
| Medtronic MiniMed, Inc. | $67.14 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.02 | 2 | Novo Nordisk Inc ($62.48) |
| 2022 | $88.19 | 1 | Insulet Corporation ($88.19) |
| 2019 | $67.14 | 1 | Medtronic MiniMed, Inc. ($67.14) |
| 2018 | $164.63 | 5 | Novo Nordisk Inc ($129.08) |
| 2017 | $131.02 | 2 | Janssen Pharmaceuticals, Inc ($131.02) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $49.54 | General |
| Category: Endocrinology | ||||||
| 05/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $62.48 | General |
| 09/15/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $88.19 | General |
| Category: Insulin Pump | ||||||
| 01/10/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $67.14 | General |
| Category: Durable Pump | ||||||
| 06/26/2018 | Novo Nordisk Inc | FIASP (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 06/26/2018 | Novo Nordisk Inc | FIASP (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 06/26/2018 | Novo Nordisk Inc | FIASP (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 06/26/2018 | Novo Nordisk Inc | FIASP (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 03/17/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $35.55 | General |
| Category: Endocrinology | ||||||
| 09/15/2017 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $6.02 | General |
| 06/10/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,875 | 5,234 | $486,077 | $135,865 |
| 2022 | 34 | 2,981 | 5,480 | $524,241 | $153,784 |
| 2021 | 42 | 2,895 | 5,186 | $453,756 | $146,273 |
| 2020 | 32 | 2,618 | 4,332 | $397,516 | $120,892 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 316 | $94,800 | $28,248 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 128 | 163 | $68,475 | $20,786 | 30.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 124 | 379 | $40,553 | $13,917 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 165 | $36,305 | $10,917 | 30.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 172 | 314 | $39,878 | $9,080 | 22.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 164 | 326 | $23,146 | $5,350 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 295 | 630 | $12,600 | $5,292 | 42.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 78 | 128 | $22,144 | $5,137 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $13,260 | $4,368 | 32.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 160 | 303 | $18,786 | $3,962 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 141 | 331 | $16,550 | $3,142 | 19.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 55 | 105 | $9,135 | $2,817 | 30.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 153 | 314 | $11,932 | $2,767 | 23.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 138 | 256 | $11,776 | $2,639 | 22.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 18 | 19 | $6,080 | $1,935 | 31.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 40 | $3,000 | $1,845 | 61.5% |
| 80069 | Kidney function blood test panel | Office | 2023 | 127 | 209 | $7,942 | $1,779 | 22.4% |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | Office | 2023 | 12 | 126 | $3,654 | $1,434 | 39.2% |
| 83735 | Magnesium level | Office | 2023 | 112 | 204 | $5,916 | $1,340 | 22.7% |
| 83721 | Ldl cholesterol level | Office | 2023 | 90 | 124 | $4,960 | $1,266 | 25.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 115 | 207 | $4,761 | $1,166 | 24.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 60 | $3,600 | $1,133 | 31.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 115 | 207 | $5,589 | $1,046 | 18.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 19 | 20 | $3,360 | $907.29 | 27.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 83 | $4,565 | $846.09 | 18.5% |
About Dr. Stuart Chipkin, M.D
Dr. Stuart Chipkin, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Amherst, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699775585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Chipkin, M.D has received a total of $563.00 in payments from pharmaceutical and medical device companies, with $112.02 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($427.90).
As a Medicare-enrolled provider, Chipkin has provided services to 11,369 Medicare beneficiaries, totaling 20,232 services with total Medicare billing of $556,814. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Amherst, MA
- Active Since 07/21/2005
- Last Updated 03/13/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1699775585
Products in Payments
- FIASP (Drug) $129.08
- INVOKANA (Drug) $125.00
- Omnipod (Device) $88.19
- Minimed 670G System (Device) $67.14
- Tymlos (Drug) $49.54
- Tymlos (Biological) $35.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Amherst
Jack Cukierman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $59,975
Shahid Haque, Md, MD
Endocrinology, Diabetes & Metabolism
Augustine Ryan, Md, MD
Endocrinology, Diabetes & Metabolism
Robert Kolodny, M.d, M.D
Endocrinology, Diabetes & Metabolism